Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effect of pyridostigmine on the hydrocortisone-mediated decrease of circulating growth hormone levels in acromegaly

A Giustina1, A R Bussi, M Doga

  • 1Cattedra di Clinica Medica, University of Brescia, Italy.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|June 1, 1994
PubMed
Summary

Pyridostigmine (PD) did not affect growth hormone (GH) secretion in acromegaly patients. However, hydrocortisone infusion significantly decreased GH levels in these patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

X-Linked Hypophosphatemia: Role of Fibroblast Growth Factor 23 on Human Skeletal Muscle-Derived Cells.

Calcified tissue international·2025
Same author

Pathophysiology and evaluation of bone health in adrenal diseases.

Endocrine·2025
Same author

Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society.

Pituitary·2025
Same author

Hypophosphatemic rickets in an Italian multicentric cohort of 24 subjects: a clinical and molecular characterisation.

Endocrine·2025
Same author

Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs).

Pituitary·2025
Same author

Metabolic, genetic and immunological features of relatives of type 1 diabetes patients with elevated insulin resistance.

Journal of endocrinological investigation·2024

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Acromegaly is a condition characterized by excessive growth hormone (GH) secretion.
  • Understanding factors influencing GH levels is crucial for managing acromegaly.

Purpose of the Study:

  • To investigate the impact of pyridostigmine (PD), an acetylcholinesterase inhibitor, on GH secretion in acromegaly.
  • To assess the effect of PD on GH levels during hydrocortisone administration in acromegaly patients.

Main Methods:

  • Five adult acromegaly patients participated in a study involving placebo and pyridostigmine administration.
  • Patients received either placebo or pyridostigmine (120 mg) followed by hydrocortisone succinate infusion or saline infusion.

Main Results:

  • Pyridostigmine administration did not significantly alter serum GH levels compared to placebo.

Related Experiment Videos

  • Hydrocortisone succinate infusion led to a notable decrease in GH levels in all acromegaly patients.

    • Conclusions:

    • Pyridostigmine does not appear to influence GH secretion in acromegaly.
    • Hydrocortisone administration effectively suppresses GH levels in acromegaly patients.